Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges
- DOI
- 10.1056/nejmoa2508228
- Published
- 2026-02-26
- Container
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1056/nejmoa2508228,
title = {Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges},
author = {Aadia I. Rana and Lu Zheng and Jose Castillo-Mancilla and Yajing Bao and Sara Sieczkarski and Kristina M. Brooks and Jordan E. Lake and Carl Fichtenbaum and Sonya L. Heath and Pablo F. Belaunzaran-Zamudio and Karin Klingman and Lawrence Fox and Tia Morton and Michael Stirratt and Jonathan Z. Li and Edward P. Acosta and Charles Venuto and Omar Galárraga and Steven Shoptaw and David Wohl and Madison Green and Ceora Beijer and Kathie Ferbas and Cheryl Jennings and Katherine Shin and Romina Collahua and Michael Dorosh and Paul Wannamaker and Ronald D’Amico and Kimberly Smith and William Spreen and Kati Vandermeulen and Rodica Van Solingen-Ristea and Chanelle Wimbish and Karen T. Tashima and Raphael J. Landovitz},
year = {2026},
journal = {New England Journal of Medicine},
doi = {10.1056/nejmoa2508228},
url = {https://doi.org/10.1056/nejmoa2508228}
}RIS
TY - JOUR TI - Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges AU - Aadia I. Rana AU - Lu Zheng AU - Jose Castillo-Mancilla AU - Yajing Bao AU - Sara Sieczkarski AU - Kristina M. Brooks AU - Jordan E. Lake AU - Carl Fichtenbaum AU - Sonya L. Heath AU - Pablo F. Belaunzaran-Zamudio AU - Karin Klingman AU - Lawrence Fox AU - Tia Morton AU - Michael Stirratt AU - Jonathan Z. Li AU - Edward P. Acosta AU - Charles Venuto AU - Omar Galárraga AU - Steven Shoptaw AU - David Wohl AU - Madison Green AU - Ceora Beijer AU - Kathie Ferbas AU - Cheryl Jennings AU - Katherine Shin AU - Romina Collahua AU - Michael Dorosh AU - Paul Wannamaker AU - Ronald D’Amico AU - Kimberly Smith AU - William Spreen AU - Kati Vandermeulen AU - Rodica Van Solingen-Ristea AU - Chanelle Wimbish AU - Karen T. Tashima AU - Raphael J. Landovitz PY - 2026 JO - New England Journal of Medicine DO - 10.1056/nejmoa2508228 UR - https://doi.org/10.1056/nejmoa2508228 ER -
APA
Rana, A. I., Zheng, L., Castillo-Mancilla, J., Bao, Y., Sieczkarski, S., Brooks, K. M., Lake, J. E., Fichtenbaum, C., Heath, S. L., Belaunzaran-Zamudio, P. F., Klingman, K., Fox, L., Morton, T., Stirratt, M., Li, J. Z., Acosta, E. P., Venuto, C., Galárraga, O., Shoptaw, S., Wohl, D., Green, M., Beijer, C., Ferbas, K., Jennings, C., Shin, K., Collahua, R., Dorosh, M., Wannamaker, P., D’Amico, R., Smith, K., Spreen, W., Vandermeulen, K., Solingen-Ristea, R. V., Wimbish, C., Tashima, K. T., & Landovitz, R. J. (2026). Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2508228
Source records
- crossref · retrieved 2026-09-26T22:05:18.303Z